- TheStreet.com•2 hours ago
Walgreens (WBA) announced a partnership with Prime Therapeutics yesterday, compelling Deutsche Bank to raise its price target on the stock on Tuesday.
- American City Business Journals•yesterday
Prime Therapeutics and Walgreens will combine their mail-order pharmacy and specialty drug businesses through a partnership announced Monday. Eagan-based Prime and Walgreens’ parent company, Deerfield, Ill.-based Walgreens Boots Alliance Inc., haven’t determined where the combined company will have its headquarters. Prime and Walgreens (WBA) will name leadership for the combined company later this year.
Walgreens Boots Alliance Inc. announced Monday that it has partnered with Prime Therapeutics, a pharmacy benefit manager owned by 14 Blue Cross and Blue Shield health plans, on a retail pharmacy network ...
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||N/A|
|Dividend & Yield||N/A (N/A)|